Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Analysis of cellular responses following interaction with extracellular vesicles derived from HEK293T and human adipose derived stem cells.

Zhang W., Obuchi S., Teramura Y.

Prospective Study on Chronic Wound, Chronic Inflammation, published in Sci Rep (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Sci Rep (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
40195493
PMCID
PMC11976929
DOI
10.1038/s41598-025-95559-w
Citations
3

Abstract (original English)

Extracellular vesicles (EVs), particularly exosomes, are crucial mediators of intercellular communication that influence immune responses, cell proliferation, and angiogenesis. Their therapeutic potential has been explored for the treatment of chronic, non-healing wounds, especially in diabetic patients with chronic inflammation, impaired cellular proliferation, and poor angiogenesis. We investigated the role of exosomes derived from human embryonic kidney 293T (HEK293T) cells and human adipose-derived stem cells (hADSCs) on NIH3T3 fibroblast migration. Exosomes were characterized for size, concentration, and surface markers. Western blotting and scratch assays were used to assess ERK1/2 activation and cell migration. Characterization revealed that HEK293T exosomes were more abundant (3.1 × 10¹¹ ± 4.9 × 10⁹ particles/mL), larger (178 ± 4 nm), and exhibited stronger surface marker protein expression than exosomes from hADSCs (2.4 × 10⁹ ± 4.1 × 10⁸ particles/mL, 153 ± 5 nm). Both types of exosomes significantly enhanced NIH3T3 fibroblast migration with migration indices of 63.2 ± 4.3% and 48.9 ± 2.7% via ERK1/2 signaling, with HEK293T exosomes showing stronger effects because of their higher protein content. Western blot analysis revealed that robust ERK1/2 activation by both exosome types was crucial for fibroblast migration, with scratch assays highlighting their pro-migratory

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansHEK293 CellsMiceCell MovementAnimalsNIH 3T3 CellsExtracellular VesiclesStem CellsAdipose TissueExosomes

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research